Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · Real-Time Price · USD
1.870
-0.060 (-3.11%)
Aug 1, 2025, 4:00 PM - Market closed
Revance Therapeutics Market Cap
Myomo has a market cap or net worth of $67.28 million as of August 1, 2025. Its market cap has decreased by -55.35% in one year.
Market Cap
67.28M
Enterprise Value
54.03M
1-Year Change
-55.35%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since June 30, 2017, Myomo's market cap has increased from $66.00M to $67.28M, an increase of 1.94%. That is a compound annual growth rate of 0.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 67.30M | -65.45% |
| Dec 31, 2024 | 194.80M | 46.69% |
| Dec 29, 2023 | 132.80M | 3,588.89% |
| Dec 30, 2022 | 3.60M | -92.34% |
| Dec 31, 2021 | 47.00M | 52.60% |
| Dec 31, 2020 | 30.80M | 492.31% |
| Dec 31, 2019 | 5.20M | -70.95% |
| Dec 31, 2018 | 17.90M | -21.83% |
| Dec 29, 2017 | 22.90M | -65.30% |
| Jun 30, 2017 | 66.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |